TRADING HALTED

Sinovac Biotech Ltd

SVA:NASDAQ
RT Quote | NASDAQ | USD
Last | 02/22/19 EST
6.47quote price arrow down-0.02 (-0.31%)
Volume
8,227
52 week range
6.25 - 6.58

...

Loading . . .

KEY STATS

  • Open6.49
  • Day High6.58
  • Day Low6.25
  • Prev Close6.47
  • 52 Week High6.58
  • 52 Week High Date02/22/19
  • 52 Week Low6.25
  • 52 Week Low Date02/22/19
  • Market Cap639.88M
  • Shares Out98.90M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.20
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)0.09
  • P/E (TTM)68.18
  • Fwd P/E (NTM)-80.88
  • EBITDA (MRQ)51.62M
  • ROE (MRQ)6.54%
  • Revenue (MRQ)264.28M
  • Gross Margin (MRQ)86.41%
  • Net Margin (MRQ)17.14%
  • Debt To Equity (MRQ)19.49%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest SVA News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Sinovac Biotech Ltd. (Sinovac) is a holding company. The Company is a biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases, including hepatitis A, hepatitis B, seasonal influenza, Haemagglutinase5 Neuraminidase1 (H5N1) and Influenza A (H1N1) pandemic influenza and mumps. The Company's pipeline consists of vaccine candidates in the clinical and pre-clinical...
WeiDong Yin
Chairman
Nan Wang
Chief Financial Officer
Qiang Gao
Vice President
Jing Li
Vice President
Xiaomei Yin
Vice President
Address
39 Shangdi Xi Road, Haidian District
Beijing, BEJ
102200
China